Amour Cbd Cream
Product Images NDC 72897-001

4 FDA label images from Svd Premium Products · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amour Cbd (NDC 72897-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Svd Premium Products, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Inactive Ingredients (Amour Inactive)

Inactive Ingredients (Amour   Inactive)
The image shows a text panel listing the inactive ingredients of Amour CBD Pain Relief Cream. Ingredients include Aloe Vera, Acrylates/C10-30 Alkyl Acrylate, Allantoin, Cetearyl Alcohol, Diazolidinyl Urea, Dimethicone, Disodium EDTA, Glycerin, Hemp Extract, Iodopropynyl Butylcarbamate, Mineral Oil, Evening Primrose Oil, Perilla Oil, Avocado Oil, Polysorbates 80, Purified Water, Stearic Acid, Tocopheryl Acetate, and Triethanolamine.*
FDA Label Image

Amourcbd (Amour Cbd Pcp And Drug Facts)

Amourcbd (Amour Cbd  Pcp And Drug Facts)
Drug Facts panel for Amour CBD Pain Relief Cream, 4 mg/100g lidocaine topical anesthetic, showing uses, warnings, directions, and inactive ingredients. The label highlights 200 mg CBD content, odor-free and THC-free, provided by SVD Premium Products. Includes barcode and contact information.*
FDA Label Image

Directions (Amour Directions)

Directions (Amour Directions)
Drug facts panel showing directions for use of Amour CBD Pain Relief Cream. It instructs adults and children over 12 years to apply a thin layer to the affected area every 6 to 8 hours, with a maximum of 3 applications in 24 hours.*
FDA Label Image

Warnings (Amour Warnings)

Warnings (Amour  Warnings)
A warning and usage instruction panel for Amour CBD Pain Relief Cream 4 mg/100g. It advises external use only, avoidance on large areas, broken skin, or puncture wounds, and limits use to one week without consulting a doctor. Directions include avoiding contact with eyes, bandages, or heat pads, and to discontinue use and consult a doctor if irritation worsens or symptoms persist. It also contains warnings for pregnant or breastfeeding users and keeping out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.